Craig Bijou
Stock Analyst at B of A Securities
(3.75)
# 760
Out of 5,102 analysts
65
Total ratings
58.33%
Success rate
51.74%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Downgrades: Neutral | $55 → $38 | $36.03 | +5.47% | 5 | Dec 8, 2025 | |
| GMED Globus Medical | Upgrades: Buy | $65 → $91 | $88.88 | +2.39% | 5 | Nov 7, 2025 | |
| RXST RxSight | Maintains: Underperform | $18 → $9 | $13.09 | -31.25% | 2 | Jul 9, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $127.25 | +10.02% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $17.27 | -1.56% | 3 | Feb 20, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $14.05 | +28.11% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $72.34 | +100.44% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $86.53 | +19.03% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $84.45 | +0.65% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $86.05 | -0.06% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $82.11 | +15.70% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $18.82 | +91.29% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.69 | +572.65% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $4.68 | +2,464.10% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.82 | +522.41% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $17.42 | -25.37% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $15.71 | +167.35% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $547.36 | -57.98% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $352.97 | -34.84% | 4 | Jul 26, 2019 |
PROCEPT BioRobotics
Dec 8, 2025
Downgrades: Neutral
Price Target: $55 → $38
Current: $36.03
Upside: +5.47%
Globus Medical
Nov 7, 2025
Upgrades: Buy
Price Target: $65 → $91
Current: $88.88
Upside: +2.39%
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $13.09
Upside: -31.25%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $127.25
Upside: +10.02%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $17.27
Upside: -1.56%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $14.05
Upside: +28.11%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $72.34
Upside: +100.44%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $86.53
Upside: +19.03%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $84.45
Upside: +0.65%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $86.05
Upside: -0.06%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $82.11
Upside: +15.70%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $18.82
Upside: +91.29%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.69
Upside: +572.65%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $4.68
Upside: +2,464.10%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.82
Upside: +522.41%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $17.42
Upside: -25.37%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $15.71
Upside: +167.35%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $547.36
Upside: -57.98%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $352.97
Upside: -34.84%